Wednesday, Sep 4, 2024 · SEC filings
What the smart money revealed on Sep 4
873 insider filings came in. We hid 123 planned (10b5-1) sellers and 601 people whose filings were routine, like grants and tax withholding.
Prospect Capital (PSEC) CEO John Barry bought $12.9M
2.5M shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
HighPeak Energy (HPK) CEO Jack Hightower bought $835K
53,905 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Dyne Therapeutics (DYN) CEO and President John Cox bought $264K
8,000 shares on the open market. Not a grant or an option exercise.
Butterfly Network (BFLY) Director Larry Robbins bought $262K
244,774 shares on the open market. Not a grant or an option exercise.
Corpay (CPAY) CEO and Chairman of BOD Ronald Clarke sold $49.5M
Not marked as a planned 10b5-1 sale. Sold 7% of the shares they held directly. Still holds 2.04M shares.
Sherwin Williams (SHW) Executive Chairman John Morikis sold $42.3M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 366,546 shares directly.
Bio-Rad Laboratories (BIO) EVP James Barry sold $206K
Not marked as a planned 10b5-1 sale. Sold 81% of the shares they held directly. Still holds 147 shares.
Show 30 more real buys
Show 83 more real sales
13F season
Holdings as of Jun 30, 2024 were due Aug 14
54 funds have filed. 50 filed for the quarter before.
Biggest real insider buys, Aug 29–Sep 4
Open-market buys by officers and directors, filed in the 7 days up to Sep 4.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.